Morsy, Khairy H, et al. “Can Eicosapentaenoic Acid Maintain the Original Ribavirin Dose or Affect the Response During the Treatment Course of Chronic Hepatitis C Virus (HCV) Patients?”. Turkish Journal of Gastroenterology, vol. 27, no. 1, Jan. 2016, pp. 55-61, doi:10.5152/tjg.2015.150280.